The appetite signal
The GLP-1 pathway is linked to fullness, slower stomach emptying, and blood-sugar control. Every molecule here acts on it.
Compare · weight-loss medicine
Semaglutide, Tirzepatide, and Retatrutide all act on the GLP-1 system, but each newer molecule adds another target, and trials tend to report more average weight loss as they do. Here is how they line up on the published data.
Average weight loss in trials
Average total body-weight reduction at the highest studied dose in each molecule's landmark trial. Different studies, populations, and timeframes, shown for general comparison only.
Semaglutide
GLP-1 · STEP 1, 2.4 mg, 68 weeks
Tirzepatide
GLP-1 + GIP · SURMOUNT-1, 15 mg, 72 weeks
Retatrutide
GLP-1 + GIP + glucagon · TRIUMPH-1 Phase 3, 12 mg, 80 weeks
Your turn
Enter your current weight and see what each medication's trial average could add up to. An "up to" estimate, never a promise.
Example projection
Retatrutide · trial average
up to 62 lb
from a 220 lb start
Trial average applied to an example, not a prediction
Side by side
| Attribute | Semaglutide | Tirzepatide | Retatrutide |
|---|---|---|---|
| Generation | First | Second | Third |
| Receptor targets | GLP-1 | GLP-1 + GIP | GLP-1 + GIP + glucagon |
| Avg. weight loss in trial | ~15%in STEP 1 | ~21%in SURMOUNT-1 | ~28%in TRIUMPH-1 |
| Landmark trial | STEP 1 (2.4 mg) | SURMOUNT-1 (15 mg) | TRIUMPH-1 (12 mg) |
| Trial length | 68 weeks | 72 weeks | 80 weeks |
| Dosing | Weekly injection | Weekly injection | Weekly injection |
| Also known as | Ozempic / Wegovy | Mounjaro / Zepbound | Exclusively at Deer |
| At Deer from | From $90 | From $230 | From $150 |
| Shop | Shop Semaglutide | Shop Tirzepatide | Shop Retatrutide |
Trial figures are averages from separate published studies, not a prediction of individual results.
How they work
The GLP-1 pathway is linked to fullness, slower stomach emptying, and blood-sugar control. Every molecule here acts on it.
Tirzepatide adds GIP, another gut hormone involved in how the body handles food energy and insulin response.
Retatrutide adds glucagon activity, which is associated with energy expenditure, on top of the GLP-1 and GIP targets.
Price · vs the alternatives
Listed Canadian pricing for comparable packages, framed per month at the trial dose. Pharmacy prices are approximate retail.
| Option | Package | Listed price | Per month |
|---|---|---|---|
| Deer Semaglutide | 10 mg pen | $140 | ~$112 |
| Apo-Semaglutide | 8 mg (2 x 4 mg) | $176Approx. retail | ~$176 |
| Ozempic | 8 mg (2 mg weekly) | $450Approx. retail | ~$450 |
Deer Semaglutide is $140 for a 10 mg pen. Apo-Semaglutide lists at about $176 for 8 mg and brand-name Ozempic at about $450 for 8 mg (Costco, Ontario).
| Option | Package | Listed price | Per month |
|---|---|---|---|
| Deer Tirzepatide | 2 x 60 mg (8 weeks) | $580 | ~$290 |
| Mounjaro | 60 mg (4 weeks) | $450Approx. retail | ~$450 |
Deer Tirzepatide is $580 for two months at 15 mg weekly (two 60 mg pens), versus about $900 over the same two months at roughly $450 per month for Mounjaro.
Pharmacy prices are approximate Canadian retail and change over time. Final totals depend on product, shipping region, and order confirmation.
Next step
Answer four questions and get matched to one of the three, or browse every weight-loss pen and build your cart.
The figures above are average results from separate published clinical trials, each with different participants, doses, and durations, and are shown only for general comparison. They are not a prediction of your results, and Deer does not claim any product will produce them. Individual results vary. This page is general education, not medical advice, and products are subject to eligibility review.